Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction (Q37022723)

17 August 2017

1 reference

title

Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction (English)

1 reference

17 August 2017

0 references

arterial hypertension

0 references

0 references

1 reference

Jeffrey S Gilbert

1

1 reference

17 August 2017

Michael J Ryan

2

1 reference

17 August 2017

Babbette B LaMarca

3

1 reference

17 August 2017

Mona Sedeek

4

1 reference

17 August 2017

Sydney R Murphy

5

1 reference

17 August 2017

Joey P Granger

6

1 reference

17 August 2017

language of work or name

1 reference

30 November 2007

1 reference

American Journal of Physiology Heart and Circulatory Physiology

17 August 2017

1 reference

17 August 2017

294

1 reference

17 August 2017

2

1 reference

17 August 2017

H541-50

1 reference

Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness

17 August 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Vascular endothelial growth factor-mediated induction of manganese superoxide dismutase occurs through redox-dependent regulation of forkhead and IkappaB/NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Vascular endothelial growth factor induces manganese-superoxide dismutase expression in endothelial cells by a Rac1-regulated NADPH oxidase-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Effect of angiotensin II synthesis blockade on the hypertensive response to chronic reductions in uterine perfusion pressure in pregnant rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Reduced uterine perfusion pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

L-arginine attenuates hypertension in pregnant rats with reduced uterine perfusion pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

High-salt diet enhances vascular reactivity in pregnant rats with normal and reduced uterine perfusion pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Insulin, insulin-like growth factor-1, and insulin resistance in women with pregnancy-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Association of maternal endothelial dysfunction with preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Experimental preeclampsia produced by chronic constriction of the lower aorta: validation with longitudinal blood pressure measurements in conscious rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Placental cytokines and the pathogenesis of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Decreased endothelium-dependent vascular relaxation during reduction of uterine perfusion pressure in pregnant rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Endothelin-1 triggers placental oxidative stress pathways: putative role in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of interleukin 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Effects of reduced uterine perfusion pressure on blood pressure and metabolic factors in pregnant rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Sympathetic neural mechanisms in normal and hypertensive pregnancy in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Endoglin regulates nitric oxide-dependent vasodilatation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women. Calcium for Preeclampsia Prevention (CPEP) Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Hypoxia and sFlt-1 in preeclampsia: the "chicken-and-egg" question

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Preeclampsia: a renal perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Systemic hemodynamics and regional blood flow during chronic nitric oxide synthesis inhibition in pregnant rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Circulating angiogenic factors and the risk of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

CD105 prevents apoptosis in hypoxic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Cytochrome P-450 inhibition attenuates hypertension induced by reductions in uterine perfusion pressure in pregnant rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Enhanced thromboxane synthesis during chronic reductions in uterine perfusion pressure in pregnant rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Hyperinsulinemia in glucose-tolerant women with preeclampsia. A controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Potential role of endothelin-1 in normal and hypertensive pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Correlation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Tales from the crypt: beta-catenin in the development of juvenile polyps: commentary on the article by Iwamoto et al. on page 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Maternal and fetal modulators of lipid metabolism correlate with the development of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Current topic: pre-eclampsia and the placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Expression of the placental cytokines tumor necrosis factor alpha, interleukin 1beta, and interleukin 10 is increased in preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Preeclampsia: an endothelial cell disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Enhanced endothelin synthesis by endothelial cells exposed to sera from pregnant rats with decreased uterine perfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Vitamins C and E and the risks of preeclampsia and perinatal complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Lipoprotein subfraction changes in normal pregnancy: threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Insulin resistance and its potential role in pregnancy-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Role of the renin-angiotensin system in the pathogenesis of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Soluble fms-Like Tyrosine Kinase 1 Is Increased in Preeclampsia But Not in Normotensive Pregnancies with Small-for-Gestational-Age Neonates: Relationship to Circulating Placental Growth Factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Systemic hemodynamic and regional blood flow changes in response to chronic reductions in uterine perfusion pressure in pregnant rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Nitric oxide and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Glucose intolerance as a predictor of hypertension in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Relation between circulating angiotensin II type 1 receptor agonistic autoantibodies and soluble fms-like tyrosine kinase 1 in the pathogenesis of preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Circulating factors as markers and mediators of endothelial cell dysfunction in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

First Trimester Placental Growth Factor and Soluble Fms-Like Tyrosine Kinase 1 and Risk for Preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Insulin resistance and alterations in angiogenesis: additive insults that may lead to preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Amniotic vascular endothelial growth factor (VEGF) and nitric oxide (NO) in women with subsequent preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Soluble endoglin contributes to the pathogenesis of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Agonistic autoantibodies directed against the angiotensin II AT1 receptor in patients with preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Eicosanoids in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

TNF alpha concentrations and mRNA expression are increased in preeclamptic placentas

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Importance of prostaglandins in hypertension during reduced uteroplacental perfusion pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Interleukin-1beta and neurogenic control of blood pressure in normal rats and rats with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Cardiovascular and renal sympathetic activation by blood-borne TNF-alpha in rat: the role of central prostaglandins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Angiotensin II induces soluble fms-Like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Increased depth of trophoblast invasion after chronic constriction of the lower aorta in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01113.2007

10.1152/AJPHEART.01113.2007

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference